US › Healthcare

Equillium Inc (EQ)

US · Healthcare · Biotechnology

$2.26+2.73%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-5.3M
Profit YoY
+38.6%
EPS
$-0.06
EPS estimate
$-0.04

EPS came in at -0.06 against a street estimate of -0.04 — a miss of 50.0%.

Key statistics

Market cap
$139.1M
Forward P/E
1.5
P/B
2.32
Book value
$0.94
EPS (TTM)
$-0.21
52-week high
$3.54
52-week low
$0.46
50-day MA
$2.74
200-day MA
$1.86
Beta
1.77

Analyst view

Analysts rate Equillium Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $8.56.

Shareholding

Insiders
16.05%
Institutions
64.87%

Largest institutional holders

FundStake
HHG PLC10.27%
Adage Capital Partners Gp LLC8.43%
Decheng Capital LLC7.03%
ADAR1 Capital Management LLC5.89%
Woodline Partners LP5.54%
Aberdeen Group PLC5.30%
RA Capital Management, LLC4.90%
Vanguard Capital Management, LLC2.82%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Equillium Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.